Disease Control and Prevention Vaccine Market, By Product Type, By Type, By Route of Administration, By Age Group, By Indication, By Geography

Description

Disease Control And Prevention Vaccine Market is estimated to be valued at USD 114.9 Bn in 2026 and is expected to reach USD 255.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 114.9 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.40%	2033 Value Projection:	USD 255.4 Bn

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Market Dynamics

The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global disease control and prevention vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
By Type (Revenue, USD Bn, 2021-2033)
- Monovalent Vaccines
- Multivalent Vaccines
By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Injectable
By Age Group (Revenue, USD Bn, 2021-2033)
- Pediatric Vaccines
- Adult Vaccines
By Indication (Revenue, USD Bn, 2021-2033)
- Infectious Diseases
- Cancer
- Other Indications
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc.
- GlaxoSmithKline plc
- Sanofi Pasteur
- Merck & Co., Inc.
- AstraZeneca PLC
- Johnson & Johnson
- Moderna, Inc.
- BioNTech SE
- Novavax, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech International Ltd.
- CSL Limited
- Dynavax Technologies Corporation
- Valneva SE Inovio Pharmaceuticals, Inc.
- Vaxart, Inc.
- Astellas Pharma Inc.
- Daiichi Sankyo Company
- Limited and Panacea Biotec Ltd.

Product Code: CMI1500

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Age Group
- Market Snippet, By Indication
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Governmental Initiative
Product Pipeline
Regulatory Landscape
PEST Analysis
PORTER'S Five Forces

4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Live-attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Disease Control and Prevention Vaccines Market, By Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global Disease Control and Prevention Vaccines Market, By Indication, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

9. Global Disease Control and Prevention Vaccines Market, By Regions, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022-2033
- Regional Trends
North America
- U.S.
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Canada
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Europe
- U.K.
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Germany
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Italy
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- France
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Spain
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Russia
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Europe
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Asia Pacific
- China
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Japan
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- India
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- ASEAN
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Australia
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- South Korea
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Asia Pacific
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Latin America
- Brazil
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Mexico
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Latin America
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Africa
- North Africa
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Central Africa
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- South Africa
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Middle East
- GCC Countries
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Israel
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Middle East
Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)

10. Competitive Landscape

Heat Map Analysis
Company Profiles
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GlaxoSmithKline plc
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi Pasteur
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca PLC
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Moderna, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- BioNTech SE
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Novavax, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sinovac Biotech Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bharat Biotech International Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CSL Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Dynavax Technologies Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Valneva SE Inovio Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Astellas Pharma Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Daiichi Sankyo Company, Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Panacea Biotec Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views

11. Section

References
Research Methodology
About Us and Sales Contact